Table 1 Patient characteristics.

From: A data-driven ultrasound approach discriminates pathological high grade prostate cancer

Ā 

Total

Cancer cases

Non-cancer cases

p value

Cases, n (images, n)

691 (2676)

436 (1691)

255 (985)

–

Age (years)

Median (IQR)

Mean (SD)

71, 65–76

69.9 ± 8.59

72, 66–77

71.3 ± 8.18

69, 62–74

67.4 ± 8.71

< 0.001

PSA (ng/mL)

Median (IQR)

Mean (SD)

8.3, 5.8–14.0

128.9 ± 1034.7

9.5, 6.7–20.5

198.9 ± 1297.5

6.6, 4.9–10.4

9.20 ± 10.38

0.002

TPV (cm3)

Median (IQR)

Mean (SD)

35.0, 25.8–50.6

42.8 ± 29.1

30.9, 23.0–42.6

37.1 ± 27.4

45.9, 32.5–62.0

52.5 ± 29.2

< 0.001

PSAD (ng/mL/cm3)

Median (IQR)

Mean (SD)

0.245, 0.138–0.482

2.85 ± 18.1

0.352, 0.207–0.681

4.39 ± 22.6

0.140, 0.0939–0.214

0.201 ± 0.288

< 0.001

Gleason score, n

6

47

47

–

–

7

215

215

Ā Ā 

8

79

79

Ā Ā 

9

94

94

Ā Ā 

10

1

1

Ā Ā 
  1. PSA prostate-specific antigen, TPV total prostate volume, PSAD PSA density, IQR interquartile range, n number, SD standard deviation.